The FAT4 gene Van Maldergem Syndrome Type 2 genetic test is a specialized diagnostic procedure offered by DNA Labs UAE, designed to detect mutations in the FAT4 gene, which are associated with Van Maldergem Syndrome Type 2. This rare genetic disorder is characterized by a range of symptoms including craniofacial abnormalities, intellectual disability, hearing loss, and skin, skeletal, and genital anomalies. Early and accurate diagnosis through genetic testing can be crucial for managing the condition, guiding treatment options, and providing genetic counseling for affected families.
The test involves collecting a DNA sample, usually through a blood draw or cheek swab, which is then analyzed in the laboratory to identify any mutations in the FAT4 gene that are indicative of Van Maldergem Syndrome Type 2. DNA Labs UAE employs advanced genetic sequencing technologies to ensure accurate and reliable results.
The cost of the FAT4 gene Van Maldergem Syndrome Type 2 genetic test at DNA Labs UAE is 4400 AED. This price may cover the testing procedure, analysis, and provision of a detailed report on the findings. Patients considering this test are advised to consult with a healthcare provider or a genetic counselor to understand the implications of the test results and to receive personalized advice based on their specific condition and family history.
The HOXD13 Gene Vater Association Genetic Test is a specialized diagnostic tool available at DNA Labs UAE, designed to identify mutations in the HOXD13 gene, which are associated with VACTERL association. VACTERL association is a rare condition characterized by the non-random co-occurrence of vertebral defects, anal atresia, cardiac defects, tracheo-esophageal fistula, renal anomalies, and limb abnormalities. The test plays a crucial role in the early detection and management of these conditions, offering insights that can guide clinical decisions and personalized care plans.
Conducted in the advanced facilities of DNA Labs UAE, this genetic test requires a sample of the patient's DNA, usually obtained through a blood draw. The process involves analyzing the specific sequences of the HOXD13 gene to identify any mutations that might predispose individuals to the components of VACTERL association.
The cost of the HOXD13 Gene Vater Association Genetic Test at DNA Labs UAE is set at 4400 AED. This price reflects the comprehensive nature of the test, encompassing the sophisticated technology and expertise required to accurately identify and interpret gene mutations. For patients and families facing the possibility of VACTERL association, this test offers valuable genetic insights that can aid in understanding their health risks and in making informed medical and lifestyle decisions.
The "DLX5 Gene Split-Hand/Foot Malformation Type 1 with Sensorineural Hearing Loss Genetic Test" is a specialized diagnostic tool available at DNA Labs UAE, designed to identify mutations in the DLX5 gene. These mutations are associated with Split-Hand/Foot Malformation Type 1 (SHFM1), a rare genetic disorder characterized by the malformation of the hands and feet, often presenting as a cleft or missing digits. Additionally, this test can detect if the genetic mutation has led to sensorineural hearing loss, a common complication associated with SHFM1.
The test is conducted through a detailed analysis of the patient's DNA, extracted from a blood sample, to look for specific genetic alterations in the DLX5 gene that are known to cause the disorder. This genetic test is crucial for early diagnosis, allowing for better management and treatment planning for individuals affected by this condition.
At DNA Labs UAE, the cost of this comprehensive genetic test is 4400 AED. This investment covers the testing process, analysis, and a detailed report of the findings, which can be invaluable for affected families seeking to understand their condition and the potential for genetic counseling.
The WNT10B Gene Split-Hand/Foot Malformation Type 6 Genetic Test is a specialized diagnostic procedure available at DNA Labs UAE, designed to identify mutations in the WNT10B gene that are associated with Split-Hand/Foot Malformation Type 6 (SHFM6). This condition is a rare genetic disorder characterized by the malformation or absence of certain fingers, toes, and occasionally long bones of the arms or legs. The test plays a crucial role in the early diagnosis and management of SHFM6, enabling healthcare providers to offer appropriate genetic counseling and consider potential treatments or interventions.
The testing process involves collecting a DNA sample from the patient, typically through a blood draw or a cheek swab, which is then analyzed in the laboratory for specific genetic alterations in the WNT10B gene known to cause the disorder. This gene plays a significant role in the development of limbs and digits during embryonic growth.
The cost of the WNT10B Gene Split-Hand/Foot Malformation Type 6 Genetic Test at DNA Labs UAE is 4400 AED. This price reflects the comprehensive nature of the test, including the advanced genetic analysis required to identify the specific mutations within the WNT10B gene. Patients considering this test are advised to consult with their healthcare providers to understand the implications of the results and to discuss the potential next steps in the management of the condition.
The NKX3-2 Gene Spondylo-Megaepiphyseal-Metaphyseal Dysplasia (SMMD) Genetic Test is a specialized diagnostic procedure aimed at identifying mutations in the NKX3-2 gene, which are responsible for causing SMMD. This rare genetic disorder is characterized by various skeletal anomalies, including abnormalities in the vertebrae, large epiphyses, and metaphyseal changes. Individuals affected by SMMD may exhibit short stature, joint pain, and limited mobility among other symptoms.
Conducted at DNA Labs UAE, this test is crucial for the accurate diagnosis of SMMD, enabling healthcare providers to tailor treatment and management plans to the specific needs of the patient. The test involves collecting a DNA sample, usually through a blood draw, which is then analyzed for the presence of mutations in the NKX3-2 gene.
The cost of the NKX3-2 Gene Spondylo-Megaepiphyseal-Metaphyseal Dysplasia Genetic Test at DNA Labs UAE is 4400 AED. This price reflects the sophisticated nature of the genetic analysis and the expertise required to interpret the results. Given the rarity and complexity of SMMD, this test represents a significant step forward in providing targeted care for individuals with this condition.
The TBX6 Gene Spondylocostal Dysostosis Type 5 Genetic Test is a specialized diagnostic procedure aimed at identifying mutations in the TBX6 gene, which are known to cause Spondylocostal Dysostosis Type 5, a rare genetic disorder characterized by abnormal development of the vertebrae and ribs. This condition often leads to a shortened trunk, scoliosis, and other spinal abnormalities that affect the overall posture and height of the individual. Early diagnosis through genetic testing can facilitate timely intervention and management of the condition, potentially improving the quality of life for those affected.
DNA Labs UAE offers this comprehensive genetic test for a cost of 4400 AED. The test is conducted in a state-of-the-art laboratory setting by skilled geneticists and technicians who specialize in genetic disorders. By analyzing the patient's DNA sample, usually obtained from a blood draw, the test seeks to identify any mutations in the TBX6 gene that would confirm the diagnosis of Spondylocostal Dysostosis Type 5. Results from the test can provide crucial information for families and healthcare providers, enabling them to make informed decisions about care and management options for affected individuals.
The B3GALT6 gene is associated with a rare genetic disorder known as Spondyloepimetaphyseal Dysplasia with Joint Laxity Type 1, with or without fractures (SEMDJL1). This condition is characterized by skeletal abnormalities, including short stature, joint laxity, and in some cases, frequent fractures. The B3GALT6 gene plays a crucial role in the biosynthesis of glycosaminoglycans, essential components of the extracellular matrix that contribute to the structural integrity of connective tissues.
To diagnose this condition accurately, a genetic test targeting the B3GALT6 gene can be performed. DNA Labs UAE offers this specialized genetic testing service, allowing for the detection of mutations in the B3GALT6 gene that are indicative of Spondyloepimetaphyseal Dysplasia with Joint Laxity Type 1. The test is crucial for confirming the diagnosis, understanding the disease's prognosis, and guiding treatment decisions.
The cost of the B3GALT6 gene test at DNA Labs UAE is 4400 AED. This test is performed using advanced genetic sequencing technologies to ensure high accuracy and reliability. By opting for this test, patients and their families can gain valuable insights into the genetic basis of the condition, enabling informed healthcare and management decisions.
The COL2A1 gene spondyloperipheral dysplasia genetic test is a specialized diagnostic tool designed to identify mutations in the COL2A1 gene, which are known to cause spondyloperipheral dysplasia—a rare genetic disorder characterized by skeletal abnormalities. This condition often presents with short stature, spinal issues, and anomalies in the peripheral bones. The COL2A1 gene plays a crucial role in the production of type II collagen, a vital component of cartilage and the vitreous humor of the eye, making its proper function essential for normal skeletal development.
Administered at DNA Labs UAE, this genetic test is meticulously designed to provide accurate and comprehensive results, offering crucial information for the diagnosis, management, and potential treatment of spondyloperipheral dysplasia. The test involves collecting a DNA sample, typically through a blood draw or a cheek swab, which is then analyzed in the lab for any mutations in the COL2A1 gene.
Priced at 4400 AED, the COL2A1 gene spondyloperipheral dysplasia genetic test is an investment in understanding and managing this rare condition. The cost reflects the sophisticated technology and expertise required to accurately identify mutations in the COL2A1 gene. For individuals showing symptoms of spondyloperipheral dysplasia or those with a family history of the condition, this test provides a crucial step towards a definitive diagnosis and the development of a tailored treatment plan.
The FBN1 Gene Stiff Skin Syndrome Genetic Test is a specialized diagnostic assessment offered by DNA Labs UAE, designed to identify mutations in the FBN1 gene, which are associated with Stiff Skin Syndrome (SSS). Stiff Skin Syndrome is a rare genetic disorder characterized by hard, thick skin that can limit joint mobility and cause discomfort. This condition is primarily caused by mutations in the FBN1 gene, which plays a crucial role in the formation of connective tissue in the body.
The test involves collecting a DNA sample, typically through a blood draw or a cheek swab, which is then analyzed in the laboratory to detect any abnormalities in the FBN1 gene that might indicate the presence of Stiff Skin Syndrome. This genetic testing is crucial for accurate diagnosis, enabling healthcare professionals to provide appropriate management and treatment plans for affected individuals.
Offered at a cost of 4400 AED, the FBN1 Gene Stiff Skin Syndrome Genetic Test at DNA Labs UAE is an essential tool for individuals experiencing symptoms of SSS or those with a family history of the condition, seeking to understand their genetic health. The test not only aids in the diagnosis but also helps in assessing the risk of passing the condition to future generations, thereby facilitating informed decisions about family planning.
The LIFR Gene Stuve-Wiedemann Syndrome Genetic Test is a specialized diagnostic tool designed to detect mutations in the LIFR gene, which are responsible for causing Stuve-Wiedemann Syndrome (SWS). This rare genetic disorder is characterized by skeletal abnormalities, muscle weakness, and difficulties in regulating body temperature. Early and accurate diagnosis through genetic testing is crucial for managing the symptoms and improving the quality of life of affected individuals.
Conducted at DNA Labs UAE, this genetic test involves analyzing the patient's DNA to identify any mutations in the LIFR gene. The process is meticulous and requires advanced technological tools to ensure accuracy. Given the complexity and the specialized nature of this test, it is priced at 4400 AED. This cost reflects the comprehensive analysis and the expertise required to interpret the results, providing families and healthcare professionals with essential information for the effective management of Stuve-Wiedemann Syndrome.
